Yair Schindel

About

Portfolio · 1

Medisafe

Medication Management Platform

1 round $1.0M committed Latest: 2013-09

Investment activity

Q&A

What is Yair Schindel's primary investment focus?

Yair Schindel, a physician-turned-investor, focuses on early and growth-stage HealthTech companies, particularly those at the intersection of biology, technology, and medicine. He co-founded aMoon Ventures in 2017 to leverage Israeli HealthTech breakthroughs.

What investment stages does Yair Schindel typically participate in?

Yair Schindel typically participates in Seed and A Round investment stages.

Can you name a notable company in Yair Schindel's portfolio?

A notable company in Yair Schindel's portfolio is Medisafe, a medication management platform. He participated in their Series C funding round.

When did Yair Schindel make his earliest recorded investment?

Yair Schindel's earliest recorded investment was in September 2013.

What is Yair Schindel's background beyond investing?

Beyond investing, Yair Schindel has a deep background in healthcare, innovation, and public service in Israel. He has held leadership roles in the Israeli government’s digital transformation initiative and in startup ecosystems.

In which sector has Yair Schindel made investments?

Yair Schindel has made investments in the Health Tech & Life Sciences sector.